Assertio Therapeutics Correlations

ASRT Stock

USD 0.76 0.04 5.56%

The current 90-days correlation between Assertio Therapeutics and Lifecore Biomedical is -0.1 (i.e., Good diversification). The correlation of Assertio Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Assertio Therapeutics Correlation With Market

Good diversification

The correlation between Assertio Therapeutics and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Assertio Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assertio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.

Moving together with Assertio Stock

0.61	CDIOW	Cardio Diagnostics	Pair Corr
0.61	ZVSA	ZyVersa Therapeutics	Pair Corr
0.73	IMRX	Immuneering Corp	Pair Corr
0.63	PYXS	Pyxis Oncology	Pair Corr
0.67	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.61	ATNF	180 Life Sciences	Pair Corr

Moving against Assertio Stock

0.62	OCX	OncoCyte Corp	Pair Corr
0.56	AZN	AstraZeneca PLC ADR	Pair Corr
0.56	SNY	Sanofi ADR	Pair Corr
0.56	GILD	Gilead Sciences Sell-off Trend	Pair Corr
0.49	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.47	GOSS	Gossamer Bio	Pair Corr
0.61	AMGN	Amgen Inc	Pair Corr
0.59	NVCT	Nuvectis Pharma	Pair Corr

Related Correlations Analysis

	AGRX	AMRX	ACRX	LFCR	IRWD	NBIX	DCPH	ESPR	ANIP	ALKS
AGRX		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	AGRX
AMRX	0.0		0.0	0.01	-0.31	-0.28	0.0	-0.37	0.39	0.34	AMRX
ACRX	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	ACRX
LFCR	0.0	0.01	0.0		0.58	0.21	0.0	0.55	-0.29	-0.51	LFCR
IRWD	0.0	-0.31	0.0	0.58		0.72	0.0	0.9	-0.71	-0.87	IRWD
NBIX	0.0	-0.28	0.0	0.21	0.72		0.0	0.69	-0.48	-0.77	NBIX
DCPH	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	DCPH
ESPR	0.0	-0.37	0.0	0.55	0.9	0.69	0.0		-0.72	-0.81	ESPR
ANIP	0.0	0.39	0.0	-0.29	-0.71	-0.48	0.0	-0.72		0.62	ANIP
ALKS	0.0	0.34	0.0	-0.51	-0.87	-0.77	0.0	-0.81	0.62		ALKS
	AGRX	AMRX	ACRX	LFCR	IRWD	NBIX	DCPH	ESPR	ANIP	ALKS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ESPR	+ 0.9	IRWD
NBIX	+ 0.72	IRWD
ESPR	+ 0.69	NBIX
ALKS	+ 0.62	ANIP
IRWD	+ 0.58	LFCR
ESPR	+ 0.55	LFCR

High negative correlations

ALKS	- 0.87	IRWD
ALKS	- 0.81	ESPR
ALKS	- 0.77	NBIX
ANIP	- 0.72	ESPR
ANIP	- 0.71	IRWD
ALKS	- 0.51	LFCR

Risk-Adjusted Indicators

There is a big difference between Assertio Stock performing well and Assertio Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Assertio Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AGRX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AMRX	1.51	0.20	0.14	(0.58)	1.52	(1.80)	3.46	(2.34)	9.89
ACRX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LFCR	2.80	(0.15)	0.00	(0.32)	0.00	0.00	3.85	(7.10)	28.39
IRWD	4.14	(0.95)	0.00	(0.56)	0.00	0.00	5.67	(10.26)	52.86
NBIX	1.50	(0.16)	0.00	(0.27)	0.00	0.00	2.19	(3.11)	21.27
DCPH	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ESPR	2.87	(0.39)	0.00	1.54	0.00	0.00	5.70	(6.51)	18.80
ANIP	1.66	0.30	0.15	0.24	1.79	(1.97)	3.04	(2.99)	18.94
ALKS	1.32	0.21	0.17	0.46	1.24	(1.61)	3.78	(2.44)	10.24

Assertio Therapeutics Corporate Management

Jack Hoblitzell	VP Operations	Profile
MD MBA	Senior Medical	Profile
Ajay Patel	VP Officer	Profile
Sam Schlessinger	Senior Counsel	Profile
Molly Dir	Senior Administration	Profile
Bill Iskos	Senior Operations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC